Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
September 14, 2004
[Autoimmune hepatitis and HCV]
Toshiki Komeda, Yoshihiro Fukuda, Susumu Imoto
Alcoholism, Clinical and Experimental Research
|
August 20, 2004
Hypervascular liver nodules in heavy drinkers of alcohol
Soo Ryang Kim, Yoko Maekawa, Susumu Imoto, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
|
December 24, 2016
Sudden-onset sarcoidosis with severe dyspnea developing during pegylated interferon and ribavirin combination therapy for chronic hepatitis C
Soo Ki Kim, Soo Ryang Kim, Susumu Imoto, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
December 24, 2015
Rhabdomyolysis due to lamivudine re-administration in a patient with HBV-related hepatic failure caused by interruption of lamivudine and adefovir
Soo Ki Kim, Soo Ryang Kim, Susumu Imoto, et al.
Hepatology (Baltimore, Md.)
|
June 10, 2008
Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy
Ahmed El-Shamy, Motoko Nagano-Fujii, Noriko Sasase, et al.
Microbiology and Immunology
|
April 21, 2007
Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera
Ahmed El-Shamy, Mikiko Sasayama, Motoko Nagano-Fujii, et al.
Intervirology
|
February 5, 2011
Polymorphisms of hepatitis C virus non-structural protein 5A and core protein and clinical outcome of pegylated-interferon/ribavirin combination therapy
Ahmed El-Shamy, Soo-Ryang Kim, Yoshi-Hiro Ide, et al.
Digestive Diseases (Basel, Switzerland)
|
October 22, 2015
Characteristics of Hypovascular versus Hypervascular Well-Differentiated Hepatocellular Carcinoma Smaller Than 2 cm - Focus on Tumor Size, Markers and Imaging Detectability
Kayo Sugimoto, Soo Ryang Kim, Susumu Imoto, et al.
Pathology International
|
July 16, 2016
Confluent hepatic fibrosis in alcohol liver cirrhosis with elevated pivkaii value - usefulness of immunostaining for EZH2 and p16(INK4a) in differentiating it from cholangiolocellular carcinoma - Confluent hepatic fibrosis
Soo Ki Kim, Soo Ryang Kim, Susumu Imoto, et al.
World Journal of Gastroenterology
|
September 1, 2010
Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm
Keiji Mita, Soo Ryang Kim, Masatoshi Kudo, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
September 14, 2004
[Autoimmune hepatitis and HCV]
Toshiki Komeda, Yoshihiro Fukuda, Susumu Imoto
Alcoholism, Clinical and Experimental Research
|
August 20, 2004
Hypervascular liver nodules in heavy drinkers of alcohol
Soo Ryang Kim, Yoko Maekawa, Susumu Imoto, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
|
December 24, 2016
Sudden-onset sarcoidosis with severe dyspnea developing during pegylated interferon and ribavirin combination therapy for chronic hepatitis C
Soo Ki Kim, Soo Ryang Kim, Susumu Imoto, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
December 24, 2015
Rhabdomyolysis due to lamivudine re-administration in a patient with HBV-related hepatic failure caused by interruption of lamivudine and adefovir
Soo Ki Kim, Soo Ryang Kim, Susumu Imoto, et al.
Hepatology (Baltimore, Md.)
|
June 10, 2008
Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy
Ahmed El-Shamy, Motoko Nagano-Fujii, Noriko Sasase, et al.
Microbiology and Immunology
|
April 21, 2007
Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera
Ahmed El-Shamy, Mikiko Sasayama, Motoko Nagano-Fujii, et al.
Intervirology
|
February 5, 2011
Polymorphisms of hepatitis C virus non-structural protein 5A and core protein and clinical outcome of pegylated-interferon/ribavirin combination therapy
Ahmed El-Shamy, Soo-Ryang Kim, Yoshi-Hiro Ide, et al.
Digestive Diseases (Basel, Switzerland)
|
October 22, 2015
Characteristics of Hypovascular versus Hypervascular Well-Differentiated Hepatocellular Carcinoma Smaller Than 2 cm - Focus on Tumor Size, Markers and Imaging Detectability
Kayo Sugimoto, Soo Ryang Kim, Susumu Imoto, et al.
Pathology International
|
July 16, 2016
Confluent hepatic fibrosis in alcohol liver cirrhosis with elevated pivkaii value - usefulness of immunostaining for EZH2 and p16(INK4a) in differentiating it from cholangiolocellular carcinoma - Confluent hepatic fibrosis
Soo Ki Kim, Soo Ryang Kim, Susumu Imoto, et al.
World Journal of Gastroenterology
|
September 1, 2010
Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm
Keiji Mita, Soo Ryang Kim, Masatoshi Kudo, et al.
Page
of 6